Cochlear Implants
It has a European CE Mark and is launching in European markets. It is not available in the United States, and we have not seen an announced U.S. timeline. So this is not a product you can ask for today. It is, though, the biggest design change in cochlear implants in a long time, and it is worth understanding, because it will shape the questions patients ask over the next few years.
Below is what has been confirmed, what has not been disclosed, and what to do now if you or someone you love may be a candidate for any cochlear implant. We perform cochlear implant candidacy evaluations and program implants after activation at our San Mateo and San Carlos offices. We do not offer TICI UNICO, and nobody in the United States does yet.
At a glance
- MED-EL announced TICI UNICO on September 29, 2026. It is fully implantable, with the microphone and battery under the skin and no external processor.
- It has a CE Mark for Europe. It is not FDA-approved and not available in the United States, and no U.S. timeline has been announced.
- It is designed for severe-to-profound sensorineural hearing loss. MED-EL reports performance comparable to its conventional implants, based on small trials.
- Pricing, MRI details and long-term results were not disclosed in the launch materials. Candidacy today still starts with aided speech testing.
What just happened
MED-EL made the announcement in Innsbruck on September 29, 2026, and said the first four commercial implantations took place on launch day. The company received a CE Mark, the European conformity approval, and is introducing the device across European markets. A MED-EL co-founder described it as a new category of implant. Outside experts are also paying attention. One expert quoted by IEEE Spectrum called it the first meaningful innovation in cochlear implants in about 30 years.
What TICI UNICO is, and how it differs from a conventional implant
A conventional cochlear implant has two halves. The inside half is surgically placed under the skin and carries an electrode array into the cochlea. The outside half, the sound processor, sits on the ear or head, picks up sound, and sends it through the skin to the implant by a magnetic coil. TICI UNICO removes the outside half. According to IEEE Spectrum, the system weighs about 20 grams and has four connected parts under the scalp, including a microphone about the width of a nickel that sits roughly 6 millimeters under the skin, and a rechargeable battery.
What invisible changes in daily life
MED-EL says the implant works around the clock. A wearer can hear while asleep, in the shower and while swimming, and can keep hearing while the battery charges. Nothing needs to be put on in the morning, and there is no processor to lose, drop or keep dry. For people who dislike the look of an external device, or who stop wearing it because of hair, glasses, sport or sleep, that could matter a great deal. The trade-off is a daily habit of a different kind: the battery is charged through the scalp with a small magnetic unit called a GoPod.
The battery and charging, in numbers
IEEE Spectrum reports a battery designed for up to about 40 hours per charge, with a charge taking one to one and a half hours. The battery cannot be replaced. The company's design goal, as reported, is at least 24 hours of use per charge for at least 15 years. Those are design targets and early reports. Real-world battery life will only be clear after years of use, and the question of what happens at the end of a battery's life is one we would want answered before recommending the device to anyone.
What the evidence shows so far
MED-EL published a six-person feasibility study in 2025 that reported safety and hearing results comparable to conventional implants. The launch material points to a larger clinical investigation of about 30 patients. Comparable results in small groups over a limited time are encouraging, and they are not the same as long-term outcomes across thousands of patients. We would treat the current evidence as a strong start, not a settled answer.
What has not been disclosed
The launch release did not give a price. It did not discuss MRI compatibility. It did not say how the under-skin microphone handles noisy rooms compared with an external microphone on the ear, and it gave no U.S. regulatory plan. Whether health plans would cover the device, and under what rules, is also unknown. These gaps are normal on launch day. They are also why we are not going to guess.
Who it is for
MED-EL designed TICI UNICO for people with severe-to-profound sensorineural hearing loss, meaning inner-ear or nerve-related loss that hearing aids can no longer make clear. Whether a person is a candidate is a clinical decision. It depends on formal testing, medical review and imaging, not on how appealing the device sounds. Nobody can self-select into an implant.
When could U.S. patients get it?
Cochlear implants in the United States are regulated as high-risk devices and need FDA approval before they can be sold. TICI UNICO does not have that approval, and we have not seen a filing date or a U.S. launch date from MED-EL. The honest answer is that we do not know, and anyone who gives you a date is guessing. We will update this page when that changes.
What cochlear implant options exist in the U.S. today
Three companies, Advanced Bionics, Cochlear and MED-EL, sell cochlear implant systems in the United States. All current U.S. systems use an external sound processor with a coil, though styles have become smaller and some sit off the ear. For the right candidate, these systems provide substantial gains in understanding speech, especially in quiet and on the telephone. Waiting for a future device has a cost of its own: the longer an ear goes without useful hearing, the less well it tends to do after implantation.
How candidacy evaluation works at our offices
We start with a full hearing test in both ears, aided and unaided, plus recorded sentence testing with your hearing aids working properly and checked with real-ear measurement. A common referral screen is a pure-tone average of 60 dB HL or worse with speech understanding of 60% or less. Medicare widened its coverage criteria in 2022, so an evaluation from before then used a stricter rule. We do the audiology workup and programming after activation. Imaging, the medical assessment and the surgery are done with an ENT surgeon at an implant center. Read more on our cochlear implants page and our explanation of the 60/60 rule.
Should you wait for TICI UNICO?
No. An evaluation does not commit you to surgery, and it tells you where you stand. If you qualify today, the evidence favors not waiting years. If you do not qualify yet, we will tell you plainly and make sure your hearing aids are verified, since an unverified fit can look like a candidacy problem. Either way, your results will still be useful if new devices arrive. You can start with a hearing evaluation.
Status and last update
Last updated September 30, 2026. What changed: this is the first version of the page. We will update it if MED-EL announces a U.S. regulatory filing, FDA approval, pricing or MRI information. Our sources: MED-EL's launch release on Business Wire, IEEE Spectrum, Hearing Practitioner News and MED-EL's 2025 feasibility study release).
Medical information notice
This page is for general information only. It is not medical advice, and it does not diagnose or recommend treatment. Whether a cochlear implant is right for you depends on testing and on a conversation with your clinical team.
Frequently asked questions
Your questions, answered
Is TICI UNICO available in the United States?
No. It has a CE Mark and is launching in Europe, but it does not have FDA approval, and we have not seen a U.S. launch date. We will update this page if that changes.
How is it different from a regular cochlear implant?
A regular implant uses an external sound processor worn on the ear or head. TICI UNICO places the microphone, battery and processing under the skin, so nothing is worn outside. The battery is charged through the scalp with a small magnetic unit.
Who qualifies for a cochlear implant?
Candidacy depends on how well you understand speech with well-fitted hearing aids, plus medical and imaging review. A pure-tone average of 60 dB HL or worse with speech understanding of 60% or less is a common reason to refer for a full evaluation. The final decision belongs to the implant team.
How do I know if I am a candidate?
Ask for a hearing evaluation that includes aided sentence testing, with hearing aids that have been checked with real-ear measurement. If the results point to an implant, we refer you to an implant center for imaging and surgical assessment.
Should I wait for TICI UNICO or get evaluated now?
Get evaluated now. An evaluation does not commit you to surgery, and time without useful hearing can reduce how well an implant works later. Your test results will still be useful if new devices reach the United States.